Actively Recruiting
Identification of Biomarkers Associated With the Presence of Malignant Pancreatic Lesions Compared to Benign Lesions.
Led by Centre Hospitalier Universitaire de Besancon · Updated on 2026-03-16
100
Participants Needed
2
Research Sites
128 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The challenge for medical oncology is to develop plasma biomarkers that can detect the influence of the stroma on diagnosis, prognosis and response to chemotherapy. Today, there is no validated blood test to help diagnose pancreatic cancer (PDAC). The search for blood biomarkers of the tumor stroma and immunological markers is therefore a major challenge in orienting the diagnosis towards PDAC and optimizing the therapeutic management of pancreatic cancers. The aim of the study is to identify biomarkers associated with the presence of malignant pancreatic lesions (patients from the Pancreas-CGE cohort, a cohort already set up by our team) compared with benign lesions (patients followed up for benign pancreatic lesions). Candidate biomarkers from our preliminary work will be considered initially. Other biomarkers may be explored secondarily. The ultimate goal is to develop a clinico-biological signature that is as efficient as possible in predicting the presence of malignant pancreatic lesions compared with benign ones.
CONDITIONS
Official Title
Identification of Biomarkers Associated With the Presence of Malignant Pancreatic Lesions Compared to Benign Lesions.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Men and women aged 18 years or older
- Patients followed for benign pancreatic lesions, including chronic pancreatitis or acute pancreatitis more than 4 weeks ago
- Indication for echo-endoscopy due to suspected precancerous pancreatic lesions or cystic lesions such as serous cystadenomas
You will not qualify if you...
- Diagnosis of malignant pancreatic tumor
- Legal incapacity or limited legal capacity
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
University Hospital of Besancon
Besançon, France
Actively Recruiting
2
Hôpital Nord Franche-Comté
Montbéliard, France
Actively Recruiting
Research Team
A
Angélique VIENOT, Dr
CONTACT
M
Marion JACQUIN
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here